Not applicableLooking for participantsNCT07056660What this trial is testingAtmospheric Pressure Cold Plasma for Moderate-to-severe Tinea PedisWho this might be right forTinea Pedis Shenyang Medical College 220
Large-scale testing (Phase 3)Study completedNCT01806597What this trial is testingStudy of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar PsoriasisWho this might be right forModerate to Severe Palmoplantar Psoriasis Novartis Pharmaceuticals 205
Large-scale testing (Phase 3)Ended earlyNCT05356403What this trial is testingCR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe PruritusWho this might be right forChronic Kidney DiseasesPruritus Cara Therapeutics, Inc. 105
Early research (Phase 1)UnknownNCT04317209What this trial is testingSHR0410 in Hemodialysis Patients With PruritusWho this might be right forPruritus Jiangsu HengRui Medicine Co., Ltd. 54
Testing effectiveness (Phase 2)Study completedNCT04365387What this trial is testingAssess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With NemolizumabWho this might be right forDermatitis, Atopic Galderma R&D 242
Large-scale testing (Phase 3)Study completedNCT02601703What this trial is testingTo Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)Who this might be right forAtopic Dermatitis Glenmark Pharmaceuticals Ltd. India 1,110
Large-scale testing (Phase 3)Study completedNCT02474069What this trial is testingSecukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type PsoriasisWho this might be right forModerate to Severe Plaque-type Psoriasis Novartis Pharmaceuticals 772
Large-scale testing (Phase 3)Study completedNCT02362789What this trial is testingSecukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional BiomarkersWho this might be right forPsoriasis Novartis Pharmaceuticals 132
Large-scale testing (Phase 3)Study completedNCT01309737What this trial is testingA One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 960
Not applicableLooking for participantsNCT07098351What this trial is testingEfficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal DialysisWho this might be right forAdverse EventPeritoneal DialysisModerate-to-severe Pruritus+1 more Guangdong Provincial People's Hospital 93
Large-scale testing (Phase 3)Study completedNCT05885737What this trial is testingPhase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe PruritusWho this might be right forUremic Pruritus Vifor Fresenius Medical Care Renal Pharma 260
Large-scale testing (Phase 3)Ended earlyNCT05387707What this trial is testingStudy to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic DermatitisWho this might be right forPruritusAtopic Dermatitis Cara Therapeutics, Inc. 287
Large-scale testing (Phase 3)Study completedNCT01276639What this trial is testingA One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 901
Large-scale testing (Phase 3)Study completedNCT01186744What this trial is testingEvaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 666
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678645What this trial is testingThe Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe ItchingWho this might be right forPrimary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)Atopic Dermatitis (AD) RenJi Hospital 44
Large-scale testing (Phase 3)Study completedNCT02210689What this trial is testingA Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant WomenWho this might be right forBACTERIAL VAGINOSISSigns and Symptoms to be Evaluated and Recorded IncludeVaginal Discharge Color, Odor, and Consistency+2 more Actavis Inc. 604
Testing effectiveness (Phase 2)Study completedNCT04018027What this trial is testingStudy to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic DermatitisWho this might be right forPruritusAtopic Dermatitis Cara Therapeutics, Inc. 401
Large-scale testing (Phase 3)Study completedNCT01636687What this trial is testingJudging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)Who this might be right forPlaque-type Psoriasis Novartis Pharmaceuticals 182
Large-scale testing (Phase 3)Study completedNCT03636269What this trial is testingCR845-CLIN3103: A Global Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe PruritusWho this might be right forUremic Pruritus Cara Therapeutics, Inc. 473
Post-approval studies (Phase 4)UnknownNCT03553433What this trial is testingApremilast Treatment for Pruritus and Quality of Life in Scalp PsoriasisWho this might be right forPsoriasis of ScalpPsoriasis Vulgaris University of Zurich 90